-transparent.png){kind=logo}
Triamcinolone acetonide aerosol, 100 microgram qid, was administered for 8 wk to 5 steroid-dependent asthmatic children and 10 who had not previously required continual corticosteroid treatment. Symptomatic control and pulmonary function improved in all 15 children despite discontinuation of oral corticosteroids in 3 of the steroid-dependent children. Determination of morning plasma cortisol concentrations disclosed no evidence of substantial adrenal suppression. Satisfactory symptomatic control has subsequently been maintained for 6 to 32 mo with doses of 100 microgram bid to 300 microgram qid without more extreme changes in plasma cortisol concentrations than were observed during the first 8 wk.
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
December 1975,
Chest,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
November 1976,
The Journal of the Kansas Medical Society,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
May 1974,
The American review of respiratory disease,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
March 1977,
Annals of allergy,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
September 1978,
Archives of internal medicine,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
March 1980,
Annals of allergy,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
June 1977,
Chest,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
May 1978,
Annals of allergy,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
May 1992,
Journal of clinical pharmacology,
R M Sly, and
M Imseis, and
M Frazer, and
F Joseph
January 1982,
The Journal of asthma : official journal of the Association for the Care of Asthma,
